TITLE

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies

AUTHOR(S)
Castéra, L.; Hézode, C.; Roudot-Thoraval, F.; Bastie, A.; Zafrani, E.-S.; Pawlotsky, J.-M.; Dhumeaux, D.
PUB. DATE
February 2003
SOURCE
Gut;Feb2003, Vol. 52 Issue 2, p288
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Steatosis, a frequent histological finding in patients with chronic hepatitis C (CHC), has been suggested to influence liver fibrosis progression. The aim of the present study was to evaluate in patients with CHC and paired liver biopsies the relationship between the evolution of steatosis and that of fibrosis between the two biopsies. Methods: Ninety six patients were selected according to the following criteria: absence of treatment; absence of cirrhosis at initial biopsy; and serum hepatitis B surface antigen and human immunodeficiency virus antibody negativity. Degrees of necroinflammatory activity, fibrosis, and steatosis grades were assessed in the two biopsies. In addition to histological lesions, parameters studied included the source of infection, duration of infection, body mass index, alcohol intake, alanine aminotransferase levels, hepatitis C virus genotype, and viral load. Results: The mean interval between the two biopsies was 48 (32) months. Steatosis was found in 54% of patients at first biopsy, and was severe in 9%. Worsening of steatosis was observed in 34% of patients, stability in 50%, and improvement in 16%. Worsening of steatosis was significantly associated with hepatic fibrosis progression in patients with (p=0.03) or without (p<0.03) steatosis at diagnosis. Overall, fibrosis progression was observed in 31% of patients and stability in 69%. In a univariate analysis, fibrosis progression was associated with male sex (p=0.05), worsening of histological activity (p=0.04), and worsening of steatosis (p=0.0003). In a multivariate analysis, the only factor independently associated with fibrosis progression was worsening of steatosis (worsening v improvement/stability: odds ratio 4.7 (95% confidence interval 1.3-10.8); p=0.0001). Conclusions: Our results suggest that in untreated patients with CHC and serial liver biopsies, fibrosis progression is strongly associated with worsening of steatosis.
ACCESSION #
9704723

 

Related Articles

  • Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection. Zubair, Alia; Jamal, Shahid; Mubarik, Azhar // Saudi Journal of Gastroenterology;Jan2009, Vol. 15 Issue 1, p11 

    Background/Aims: To quantitatively assess steatosis by a morphometric method and to study its relationship with other histological features of chronic hepatitis C (CHC). This was a comparative descriptive study. The study was carried out in the Department of Histopathology, Army Medical College,...

  • Association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Syed, Shuja Izhar; Sadiq, Saleem // Pakistan Journal of Medical Sciences;Apr2011, Vol. 27 Issue 3, p638 

    Objective: To find out the association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Methodology: This was a prospective study based on liver biopsies of hepatitis C patients. H and E stained slides were examined to determine the histological...

  • IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients. Ohnishi, Mayu; Tsuge, Masataka; Kohno, Tomohiko; Zhang, Yizhou; Abe, Hiromi; Hyogo, Hideyuki; Kimura, Yuki; Miki, Daiki; Hiraga, Nobuhiko; Imamura, Michio; Takahashi, Shoichi; Ochi, Hidenori; Hayes, C.; Tanaka, Shinji; Arihiro, Koji; Chayama, Kazuaki // Journal of Gastroenterology;Jul2012, Vol. 47 Issue 7, p834 

    Background: Several single nucleotide polymorphisms (SNPs) within the interleukin 28B ( IL28B) locus are associated with sustained viral response in chronic hepatitis C (HCV) patients who were treated with pegylated interferon (PEG-IFN) plus ribavirin (RBV) combination therapy. Recently, an...

  • Lipid and carbohydrate parameters in children with chronic hepatitis C. Wiśniewska-Ligier, M; Konopka, A; Woźniakowska-Gęsicka, T // Advances in Medical Sciences (De Gruyter Open);2011, Vol. 56 Issue 2, p180 

    Purpose: HCV chronic infection still presents a very serious epidemiological and clinical problem. Apart from its cytopathic effect on liver parenchyma, its detrimental effect on lipid and carbohydrate metabolism has recently been emphasized. The aim of the study was to assess lipid and...

  • SERUM LIPOPROTEINS AND CHRONIC HEPATITIS C INFECTION; IMPORTANCE OF INVERSE RELATIONSHIP. Liaquat, Jahangir; Bawany, Muhammad Adnan; Shuaib Ansari; Khahro, Adnan Ali; Naz, Falak; Khanzada, Shereen Rahat // Professional Medical Journal;2014, Vol. 21 Issue 2, p302 

    Objectives: To determine the serum lipid profile in patients with chronic HCV infection and correlation between serum lipid levels and liver histology. Material and methods: Descriptive study was carried out in Medical Unit I of Liaquat University Hospital Jamshoro Hyderabad, from September 2007...

  • Increased α-Fetoprotein Predicts Steatosis among Patients with Chronic Hepatitis C Genotype 4. Mousa, Nasser; Gad, Yahia; Abdel-Aziz, Azza; Abd-Elaal, Ibrahem // International Journal of Hepatology;2012, p1 

    Background. The prognostic importance of α-fetoprotein (AFP) level elevation in patients with chronic hepatitis C and its clinical significance in steatosis associated with HCV infection remain to be determined. The present paper assessed clinical significance of elevated AFP in patients with...

  • Serum Apoptosis Markers Related to Liver Damage in Chronic Hepatitis C: sFas as a Marker of Advanced Fibrosis in Children and Adults While M30 of Severe Steatosis Only in Children. Valva, Pamela; Casciato, Paola; Lezama, Carol; Galoppo, Marcela; Gadano, Adrián; Galdame, Omar; Galoppo, María Cristina; Mullen, Eduardo; De Matteo, Elena; Preciado, María Victoria // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Background: Liver biopsy represents the gold standard for evaluating damage and progression in patients with chronic hepatitis C (CHC); however, developing noninvasive tests that can predict liver injury represents a growing medical need. Considering that hepatocyte apoptosis plays a role in CHC...

  • IL28B Gene Polymorphisms and US Liver Fatty Changes in Patients Who Spontaneously Cleared Hepatitis C Virus Infection. Taliani, Gloria; Spaziante, Martina; Biliotti, Elisa; Borro, Marina; Palazzo, Donatella; Grieco, Stefania; Franchi, Cristiana; Iaiani, Giancarlo; Furlan, Caterina; Gallinaro, Valentina; Simmaco, Maurizio // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background: Recent clinical studies have shown that the presence of CC genotype in the rs12979860 region of IL28B gene is associated with an increase in the probability of spontaneous clearance of hepatitis C virus (HCV). Moreover, IL28B polymorphism seems to influence the probability of...

  • Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Romero-Gómez, Manuel; Castellano-Megias, Victor M.; Grande, Lourdes; Irles, José A.; Cruz, Marina; Nogales, Marí Carmen; Alcón, Juan Carlos; Robles, Antonio // American Journal of Gastroenterology;May2003, Vol. 98 Issue 5, p1135 

    : ObjectivesHepatic steatosis (HS) has been related to obesity and fibrosis in chronic hepatitis C (CHC). The aim of this study was to determine the role of leptin system in HS development.: MethodsPatients (n = 131) with biopsy-proven CHC, positive HCV RNA, and raised ALT were enrolled. Body...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics